Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2006 2
2007 3
2008 1
2009 3
2010 3
2011 5
2012 4
2013 3
2014 5
2015 6
2016 4
2017 1
2019 6
2020 3
2021 4
2022 5
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.
Functional neuronal circuits promote disease progression in cancer.
Restaino AC, Walz A, Vermeer SJ, Barr J, Kovács A, Fettig RR, Vermeer DW, Reavis H, Williamson CS, Lucido CT, Eichwald T, Omran DK, Jung E, Schwartz LE, Bell M, Muirhead DM, Hooper JE, Spanos WC, Drapkin R, Talbot S, Vermeer PD. Restaino AC, et al. Among authors: bell m. Sci Adv. 2023 May 10;9(19):eade4443. doi: 10.1126/sciadv.ade4443. Epub 2023 May 10. Sci Adv. 2023. PMID: 37163587 Free PMC article.
ACR Appropriateness Criteria® Gestational Trophoblastic Disease.
Expert Panel on Women’s Imaging Panel; Dudiak KM, Maturen KE, Akin EA, Bell M, Bhosale PR, Kang SK, Kilcoyne A, Lakhman Y, Nicola R, Pandharipande PV, Paspulati R, Reinhold C, Ricci S, Shinagare AB, Vargas HA, Whitcomb BP, Glanc P. Expert Panel on Women’s Imaging Panel, et al. Among authors: bell m. J Am Coll Radiol. 2019 Nov;16(11S):S348-S363. doi: 10.1016/j.jacr.2019.05.015. J Am Coll Radiol. 2019. PMID: 31685103 Review.
Teleoncology for gynecologic cancers.
Shalowitz DI, Smith AG, Bell MC, Gibb RK. Shalowitz DI, et al. Among authors: bell mc. Gynecol Oncol. 2015 Oct;139(1):172-7. doi: 10.1016/j.ygyno.2015.06.042. Epub 2015 Jul 5. Gynecol Oncol. 2015. PMID: 26151077 Review.
Intra-Tumoral Nerve-Tracing in a Novel Syngeneic Model of High-Grade Serous Ovarian Carcinoma.
Barr JL, Kruse A, Restaino AC, Tulina N, Stuckelberger S, Vermeer SJ, Williamson CS, Vermeer DW, Madeo M, Stamp J, Bell M, Morgan M, Yoon JY, Mitchell MA, Budina A, Omran DK, Schwartz LE, Drapkin R, Vermeer PD. Barr JL, et al. Among authors: bell m. Cells. 2021 Dec 10;10(12):3491. doi: 10.3390/cells10123491. Cells. 2021. PMID: 34944001 Free PMC article.
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018).
Arend RC, Monk BJ, Shapira-Frommer R, Haggerty AF, Alvarez EA, Amit A, Alvarez Secord A, Muller C, Casado Herraez A, Herzog TJ, Tewari KS, Cohen JG, Huang M, Yachnin A, Holeman LL, Ledermann JA, Rachmilewitz Minei T, Buyse M, Fain Shmueli S, Lavi M, Harats D, Penson RT; OVAL/GOG-3018 Investigators. Arend RC, et al. J Clin Oncol. 2024 Jan 10;42(2):170-179. doi: 10.1200/JCO.22.02915. Epub 2023 Oct 31. J Clin Oncol. 2024. PMID: 37906726 Clinical Trial.
My view.
Allison ML, Stransky JJ, Bell M. Allison ML, et al. Among authors: bell m. S D Med. 2006 Jul;59(7):310-4. S D Med. 2006. PMID: 16895056 No abstract available.
Cervical cancer prevention: new tools and old barriers.
Scarinci IC, Garcia FA, Kobetz E, Partridge EE, Brandt HM, Bell MC, Dignan M, Ma GX, Daye JL, Castle PE. Scarinci IC, et al. Among authors: bell mc. Cancer. 2010 Jun 1;116(11):2531-42. doi: 10.1002/cncr.25065. Cancer. 2010. PMID: 20310056 Free PMC article. Review.
Treatment of estrogen-induced dermatitis with omalizumab.
Ocana JA, Bell MC, Heskett JB, Baker WH, Mousdicas N, Turner MJ. Ocana JA, et al. Among authors: bell mc. JAAD Case Rep. 2019 May 25;5(6):481-483. doi: 10.1016/j.jdcr.2019.03.007. eCollection 2019 Jun. JAAD Case Rep. 2019. PMID: 31193571 Free PMC article. No abstract available.
65 results